Obesity is now a worldwide epidemic ensuing an increase in comorbidities' prevalence,
such as insulin resistance, type 2 diabetes (T2D), metabolic dysfunction-associated fatty …

Non-alcoholic fatty liver (NAFLD) is the most common liver disease worldwide, progressing
from simple steatosis to necroinflammation and fibrosis (leading to non-alcoholic …

The consumption of carotenoids has beneficial effects on health, reducing the risk of certain
forms of cancer, cardiovascular diseases, and macular degeneration, among others. The …

According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide and its incidence is definitely increasing. NAFLD is a metabolic disease with …

Non-alcoholic fatty liver disease (NAFLD) is a common clinicopathological condition,
encompassing a range of conditions caused by lipid deposition within liver cells. To date, no …

Oxidative stress plays a major role in acute and chronic liver injury. In hepatocytes, oxidative
stress frequently triggers antioxidant response by activating nuclear erythroid 2‐related …

Objective Several studies have documented a relationship between non-alcoholic fatty liver
disease (NAFLD) and structural heart disease, particularly diastolic function. This meta …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) is associated with increased
cardiovascular risk. Among categories of NAFLD, hepatic fibrosis is most likely to affect …

Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM)
in humans and mouse disease models. Obesity and DM are a well-established independent …